JWCTF
Price
$0.25
Change
+$0.09 (+56.25%)
Updated
May 29 closing price
Capitalization
147.38M
SRRK
Price
$35.81
Change
+$0.33 (+0.93%)
Updated
Jun 27 closing price
Capitalization
3.4B
38 days until earnings call
Interact to see
Advertisement

JWCTF vs SRRK

Header iconJWCTF vs SRRK Comparison
Open Charts JWCTF vs SRRKBanner chart's image
JW CAYMAN THERAPEUTICS
Price$0.25
Change+$0.09 (+56.25%)
Volume$57K
Capitalization147.38M
Scholar Rock Holding
Price$35.81
Change+$0.33 (+0.93%)
Volume$1.74M
Capitalization3.4B
JWCTF vs SRRK Comparison Chart in %
Loading...
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JWCTF vs. SRRK commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JWCTF is a Hold and SRRK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (JWCTF: $0.25 vs. SRRK: $35.81)
Brand notoriety: JWCTF and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JWCTF: 218% vs. SRRK: 135%
Market capitalization -- JWCTF: $147.38M vs. SRRK: $3.4B
JWCTF [@Biotechnology] is valued at $147.38M. SRRK’s [@Biotechnology] market capitalization is $3.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JWCTF’s FA Score shows that 1 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • JWCTF’s FA Score: 1 green, 4 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, JWCTF is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JWCTF’s TA Score shows that 3 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).

  • JWCTF’s TA Score: 3 bullish, 2 bearish.
  • SRRK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, JWCTF is a better buy in the short-term than SRRK.

Price Growth

JWCTF (@Biotechnology) experienced а 0.00% price change this week, while SRRK (@Biotechnology) price change was +5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.4B) has a higher market cap than JWCTF($147M). JWCTF YTD gains are higher at: 54.321 vs. SRRK (-17.145).
JWCTFSRRKJWCTF / SRRK
Capitalization147M3.4B4%
EBITDAN/A-268.99M-
Gain YTD54.321-17.145-317%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A364M-
Total DebtN/A63.1M-
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JWCTFSRRK
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
41%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
29%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
25%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
19%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EITGX56.210.42
+0.75%
Eaton Vance Tx-Mgd Growth 1.2 I
LAFCX19.830.12
+0.61%
Lord Abbett Affiliated C
MXLSX37.390.12
+0.32%
Empower Small Cap Value Inv
CUSIX13.070.01
+0.08%
Cullen Small Cap Value I
ASEFX14.740.01
+0.07%
Nuveen Small Cap Select R6

JWCTF and

Correlation & Price change

A.I.dvisor tells us that JWCTF and HSITF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JWCTF and HSITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JWCTF
1D Price
Change %
JWCTF100%
N/A
HSITF - JWCTF
25%
Poorly correlated
N/A
CAPR - JWCTF
24%
Poorly correlated
+9.53%
SRRK - JWCTF
24%
Poorly correlated
+0.93%
INTS - JWCTF
23%
Poorly correlated
N/A
SRZN - JWCTF
15%
Poorly correlated
+8.02%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with PLRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
+0.93%
PLRX - SRRK
40%
Loosely correlated
-3.08%
SNDX - SRRK
39%
Loosely correlated
-2.80%
VTGN - SRRK
39%
Loosely correlated
-3.90%
ALT - SRRK
37%
Loosely correlated
-54.60%
AVXL - SRRK
37%
Loosely correlated
-0.94%
More